What does Endoline do?

Endoline is a specialist medical practice in Lille. Private Limited, started on 17 November 2023, 1 establishment.

What is the address of Endoline?

The registered office of Endoline is located at Gagelveld 29, 2275 Lille.

Is Endoline still active?

Yes. According to the CBE (30 October 2026) Endoline is active, legal situation “Normale toestand”, started on 17 November 2023.

Is Endoline registered on Peppol?

Yes, Endoline is registered on the Peppol network with ID 0208:1002392357.

What is the enterprise number of Endoline?

The enterprise number of Endoline is BE1002392357.

When was Endoline founded?

Endoline was founded on 17 November 2023.

Who are the directors of Endoline?

According to the 2025 annual accounts, the directors of Endoline are: Eveline LEFEVER.

Is Endoline a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 17 November 2023; 2 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Endoline make in 2025?

Endoline posted a profit after taxes of € 73,285 in financial year 2025.

What is the revenue of Endoline?

As a small company, Endoline is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 102,295.

Endoline (Private Limited) - Lille - BE1002392357

Dossier Endoline, printed on 30 October 2026 from databakkes.be/en/1002392357/endoline. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Endoline from Lille, company number BE1002392357, closed financial year 2025 with a result of € 73,285 after tax. For that financial year Endoline recorded a gross margin of € 102,295 and equity of € 105,465. Compared with financial year 2024, the result moved from € 29,179 to € 73,285. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on December 17, 2025.

What it is worth Growing

€ 105,465

▲ 228% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 73,285

▲ 151% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 66,941

▲ € 60,617 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 102,465.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Wage cost estimate Staff cost at a one-person company Staff Only people on the payroll count here.€ 1,243 Likely the director’s social contribution or pension premium.The director’s pay Already netted into the gross margin, not shown separately in the accounts. Typical for one-person companies € 45,000 gross per year minimum for the reduced tax rate≈ € 2,100 net per month after contributions, tax and usually some benefits in kind, roughly Assumption based on the chart of accounts, not a figure from the source.

€ 1,243

▲ 125% vs 2024

No payroll staff. An amount this small is usually a social contribution or pension premium for the director, booked under staff costs.

Vehicles and equipment

€ 46,033

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 44,690

€ 9,325 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 227

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 18,967

▲ 104% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2024	2025	Change 2024 → 2025
Gross margin	€ 38,119 Gross margin 2024: € 38,119 First fiscal year in the series	€ 102,295 Gross margin 2025: € 102,295 ▲ 168% vs 2024 (€ 38,119) Favourable step	▲ 168%
Profit after taxes	€ 29,179 Profit after taxes 2024: € 29,179 First fiscal year in the series	€ 73,285 Profit after taxes 2025: € 73,285 ▲ 151% vs 2024 (€ 29,179) Favourable step	▲ 151%
Equity	€ 32,179 Equity 2024: € 32,179 First fiscal year in the series	€ 105,465 Equity 2025: € 105,465 ▲ 228% vs 2024 (€ 32,179) Favourable step	▲ 228%
Total debts	€ 10,595 Total debts 2024: € 10,595 First fiscal year in the series	€ 63,885 Total debts 2025: € 63,885 ▲ € 53,290 vs 2024 (€ 10,595) Unfavourable step	▲ € 53,290
Cash	€ 6,325 Cash 2024: € 6,325 First fiscal year in the series	€ 66,941 Cash 2025: € 66,941 ▲ € 60,617 vs 2024 (€ 6,325) Favourable step	▲ € 60,617
Land & buildings	-	€ 983 Land & buildings 2025: € 983 First fiscal year in the series
Retained profit	€ 29,179 Retained profit 2024: € 29,179 First fiscal year in the series	€ 102,465 Retained profit 2025: € 102,465 ▲ 251% vs 2024 (€ 29,179) Favourable step	▲ 251%
Bank debt	€ 0 Bank debt 2024: € 0 First fiscal year in the series	€ 44,690 Bank debt 2025: € 44,690 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 42,774 Balance sheet total 2024: € 42,774 First fiscal year in the series	€ 169,349 Balance sheet total 2025: € 169,349 ▲ 296% vs 2024 (€ 42,774) Unchanged	▲ 296%

Key figures of Endoline, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to Endoline?

What happened at Endoline in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Dec 17, 2025 New annual accounts for financial year 2025: profit of € 73,285 (▲ 151% vs 2024). Source: NBB ↗
Nov 17, 2023 New establishment in Lille. KBO
Nov 17, 2023 Start of the company according to the CBE. KBO
2023 Eveline LEFEVER became a director. NBB

In short

From € 29,179 profit in 2024 to € 73,285 profit in 2025.

Paid € 26,737 in corporate taxes since 2024.

Best year ever: 2025, with € 73,285 profit.

Original PDFs at the National Bank ↗

Management

Eveline LEFEVER

Endoline

Associatie Nefrologie-Endocrinologie 11.1%

Behind Endoline is Eveline LEFEVER. It owns 11.1% of Associatie Nefrologie-Endocrinologie itself.

Directors

According to the 2025 annual accounts

Eveline LEFEVER

Director

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Gagelveld 29

2275 Lille

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

1002.392.357

VAT number

BE 1002.392.357

Registered office

Gagelveld 29, 2275 Lille

Names & denominations

Endoline

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

17 November 2023

Peppol

Active · Active since 11 Dec 2025

Activities · NACE

Activiteiten van medisch specialisten

Overige vormen van onderwijs

View on CBE Public ↗ Annual accounts (NBB) ↗

Endoline

Financials

What happened to Endoline?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions